Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.
Exheus has raised $671K in total funding. The most recent round was Pre-Seed. The last funding was announced in November 2022.
Exheus's investors include Google for Startups, Decelera, Capital Cell, WA4STEAM.
Exheus is headquartered in Barcelona, Spain.
Exheus is provider of direct-to-consumer gene expression report that helps to optimise people’s health in a highly personalised way.
Exheus is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Exheus — Funding & Investors." VCBacked, November 29, 2022, https://www.vcbacked.co/company/exheus. Accessed August 1, 2026.
VCBacked. (2022). Exheus — Funding & Investors. Retrieved August 1, 2026, from https://www.vcbacked.co/company/exheus
{{cite web |title=Exheus — Funding & Investors |url=https://www.vcbacked.co/company/exheus |website=VCBacked |access-date=August 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated